Drug of Abuse Testing Services Market Outlook 2031:
The global drug of abuse testing services market size was valued at USD 3.10 Million in 2022 and is projected to reach USD 4.93 Million by 2031, expanding at a CAGR of 5.3% during the forecast period 2023 - 2031. The growth of this market is attributed to the rise in consumption of illegal drugs such as marijuana and cocaine along with the increasing number of clinical laboratories.
Governments are aware of the negative effects of drugs especially for under aged children and several organizational workplaces. They have introduced initiatives to combat and monitor the substance abuse present in their respective regions.
The United Nations Office of Drugs and Crime (UNODC) 2020 data shows that 40 million people uses several treatment to cure themselves from substance use disorders. The illicit drugs and alcohol causes addiction when used high amounts, which can therefore cause life threatening consequences.
Availability and access of treatment services globally is extremely limited to cure substance use disorders. In developed countries such as the US, the demand for substance use disorders treatment and healthcare centers are constantly increasing to combat this illness. The National Control Budget, US, has announced five key platforms for drug control functional namely prevention, treatment, interdiction, operation, and law enforcement.
This funding is estimated to reach nearly USD 36 billion by the end of 2021. The Substance Abuse and Mental Health Services Administration or the SAMHSA have received USD two billion for the substance use disorder prevention studies and other research processes. The US Department of Defense has also requested USD 1.5 billion for the constant monitoring of drug interaction operations and counterdrug actions in the country.
Drug of Abuse Testing Services Market Trends, Drivers, Restraints, and Opportunities
- Growing number of clinics that offer drugs of substance use disorder testing services acts as a major driver for the drugs of abuse testing services market.
- A major increase in clinical laboratories, hospitals, and other testing centers for the treatment of substance use disorder also contributes to the growth of this market.
- High cost of laboratory screening diagnostics and rising use of disposable equipment are key restraining factors expected to hamper the market growth.
- Rising awareness about the substance use disorders and introduction of several advanced treatment products or devices that can help to prevent this illness. This is projected to act as a key driver for the market.
- The outbreak of COVID-19 pandemic has affected the market growth due to the strict lockdown protocols and putting halt in the distribution of the drugs freely from governments.
Scope of the Drug of Abuse Testing Services Market Report
The report on the global drug of abuse testing services market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Drug of Abuse Testing Services Market – Global Industry Analysis, Growth, Share, Size, Trends and Forecast
Drug Types (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, Lysergic Acid Diethylamide, and Others)
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast
Key Players Covered in the Report
Quest Diagnostics; Abbott Laboratories; Clinical Reference Laboratory (CRL), Inc; Laboratory Corporation of American Holdings; Cordant Health Solutions; Legacy Medical Services; DrugScan; Omega Laboratories, Inc; Psychemedics Corporation; Millennium Health; Mayo Clinic Laboratories; Precision Diagnostics; American Substance Abuse Professionals (ASAP), Inc; United States Drug Testing Laboratories (USDTL), Inc; and Laboratory of the Government Chemist (LGC) Group
Global Drug of Abuse Testing Services Market Segment Insights
Cannabis/Marijuana segment dominated the market with 27% in 2020
On the basis of drug types, the global drug of abuse testing services market is segmented into alcohol, cannabis/marijuana, cocaine, opioids, Amphetamine & Methamphetamine, Lysergic Acid Diethylamide (LSD), and others. The cannabis/marijuana segment held a large share of this market representing with 27% revenue share of the global market.
This segment is expected to dominate the market in the coming owing to wide abuse of cannabis or marijuana among a large number of adult population globally. The opioids segment is currently the second largest holding more than 22% share of the global market. The increasing opioid crisis in North America and Europe are the main reason for the large share of the opioid segment.
According to a survey conducted by the Drug Abuse Statistics in 2020, five million people have been reported to using cannabis or marijuana, out of which two million people are from the US alone.
North America to account for a large share
Based on regions, the global drug of abuse testing services market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa North America is anticipated to account for a large market share in the coming years, which represented 39% share of the global market. The key factors attributing to the regional growth is the increasing awareness of the substance use disorder and the initiatives taken by various regional governments to monitor, control and combat it.
According to the National Control budget, the COVID-19 pandemic has increased the demand of the services and treatments of substance use disorder in North America. Meanwhile, the market in Asia Pacific is expected to exhibit a robust CAGR during the forecast period, 2021-2028.
Emerging economies such as India are now leveraging to spread awareness about the importance of substance use disorder treatments and several healthcare initiatives regarding the treatment. This is one of the major driving factors for the regional market growth.
The drug of abuse testing services market has been segmented in terms of
- Amphetamine & Methamphetamine
- Lysergic acid Diethylamide (LSD)
- Asia Pacific
- North America
- Latin America
- Middle East & Africa
- Quest Diagnostics
- Abbott Laboratories
- Clinical Reference Laboratory (CRL), Inc
- Laboratory Corporation of American Holdings
- Cordant Health Solutions
- Legacy Medical Services
- Omega Laboratories, Inc
- Psychemedics Corporation
- Millennium Health; Mayo Clinic Laboratories
- Precision Diagnostics
- American Substance Abuse Professionals (ASAP), Inc
- United States Drug Testing Laboratories (USDTL), Inc
- Laboratory of the Government Chemist (LGC) Group.
Some of the key players in the global drug of abuse testing services market are Quest Diagnostics; Abbott Laboratories; Clinical Reference Laboratory (CRL), Inc; Laboratory Corporation of American Holdings; Cordant Health Solutions; Legacy Medical Services; DrugScan; Omega Laboratories, Inc; Psychemedics Corporation; Millennium Health; Mayo Clinic Laboratories; Precision Diagnostics; American Substance Abuse Professionals (ASAP), Inc; United States Drug Testing Laboratories (USDTL), Inc; and Laboratory of the Government Chemist (LGC) Group.
Many of these companies are constantly adopting different growth strategies including product development, expansion of geographical reach, and product differentiation. Companies also undergo mergers and acquisitions to have a competitive edge. Psychemedics Corporation, for instance, signed a new distribution agreement with Sansao Holding S.A and Toxicologia Pardini Ltda in Brazil. The former company now has access to the Brazilian distribution network of their drug of abuse testing services market.